Despite a daily loss of 3.9% and a 3-month loss of 3.4%, Repligen Corp (NASDAQ:RGEN) shows a promising Earnings Per Share (EPS) of 2.42. This raises a compelling question: Is the stock significantly undervalued? Repligen Corp is a leading life sciences company with a global presence. It is renowned for developing and commercializing innovative bioprocessing...
RGEN - Shorter swing trade with a tight stop @ the 8 EMA; Nice consolidation with 8 & 21 EMA; above the 200 MA. Nice Earnings history; nice FIB pullback and some good risk/reward.
Assalamualaikum and greeting. Below my expectation of this stock company Technical 1. Price on Uptrend and go for retrace 2. Price now hit EMA 200 and expected to rebound 3. The setup of Bullish Divergence clearly seen in MACD Indicator 4. MACD signal had give crossover 5. Volume is nice Fundamental 1. Almost zero debt 2. High Net Margin I vote to Buy
$RGEN 2 months into its base building after a 100% strong run from May bottom. CANSLIM earnings, sales, growth, group strength and sponsorship. Base doesn't look complete yet but defiantly one you want to add to your watchlist.
Fantastic breakout on $RGEN - Waiting for a pullback to entry Too overextend at the moment.
RGEN watch this for a break above $212.55
RGEN is going to dip if you feel you’re going to take a loss on this stock I would advise selling sooner rather then later. The chart that I’ve referenced is the Vortex Indicator and from my analysis the lines are going to cross negatively. So I advise selling while you still have gains on it. Reminder this is only an opinion I cannot be held responsible for any...
Entry price : 188.21 Fundamentals : - Sector: Medical - Medical Products - EPS % Chg (Last Qtr): 54% - EPS % Chg (Previous Qtr): 27% - 3 Year EPS Growth Rate: 31% - EPS Est % Chg (Current Yr): 35% - Sales % Chg (Last Qtr): 35% - Sales % Chg (Previous Qtr): 24% - 3-Year Sales Growth Rate: 37% - Annual Pre -Tax Margin: 24.9%
NASDAQ:RGEN Well below average volume with VCP action. It is showing good RS with the 50 day MA within rage. I'd like to see it put in a couple more consolidation days before it takes out that 200.19 high.
RGEN had had been pulling back after hitting 212 on 12 Nov. On 20 Nov it staged a rebound to 197 but it proved to be short lived as it soon gave way to another plunge to 177, closing a prior gap at 178. There is stronger reason now to believe that this time the rebound will follow through due to 1) gap fill and 2) bullish divergence between price and RSI. Going...
Opening price : 178.47 SL: 172.01 (-3.62%) TP: 197.86 (+10.86%) R:R: 3 Fundamentals : EPS % Chg (Last Qtr): 27% 3 Year EPS Growth Rate: 29% EPS Est % Chg (Current Yr): 20% Sales % Chg (Last Qtr): 24% 3-Year Sales Growth Rate: 39% Annual Pre -Tax Margin: 24.9% Story : The Company is focused on the development, manufacture and commercialization of products used...
RGEN I had plans to post before but now I want to update this plan separately because it looks better than before. - Cup and Handle pattern (with the right-hand Gap acts as the handle). - Confirm " symmetrical triangle " pattern above the Cup. Rgen buy : $155 Rgen target : $180+ Stop loss : $150 Wish you a good deal !
RGEN confirmed to break out of Coc, with the appearance of Gap on the right instead of the handle (Gap is big support) so you can understand this is the "Cup and Handle" pattern . RGEN buy : $147 +- 0,5 RGEN target : $180 +-1 Stop loss : 10% Wish you good deals!
RGEN has been in a strong uptrend for a while, making a short a risky trade. Going to take a shot at it anyway. Basic idea is the SMAs are spread, giving them some time to meet up again. Shown in two blue circles, previously the price would dip just under the SMA200 before taking off again. The target is the 0.618 FIB retracement, which lines up with the SMA200...